About | Free Trial

Last Update


This profile was last updated on . .

Is this you? Claim your profile.

Wrong Ivan Horak?

Dr. Ivan Horak D.

Chief Scientific and Medical Officer

Symphogen Inc

Direct Phone: (908) ***-****       

Email: i***@***.com

Symphogen Inc

50 Division St Suite 503

Somerville, New Jersey 08876

United States

Company Description

With its pioneering antibody discovery and manufacturing technologies, Symphogen aims to create, develop, manufacture and commercialize target-specific recombinant antibodies that mimic the natural diversity and specificity of the human immune response. S... more

Find other employees at this company (101)

Background Information

Employment History

American Society of Hematology

Third Wave Technologies Inc

President for Research and Development, Chief Scientific Officer

Enzon Pharmaceuticals , Inc.

Chief Scientific Officer

Immunomedics , Inc.

CSO and Chief Marketing Officer

The Global Leaders

Chief Scientific Officer and President of Research and Development


Vice President for Clinical Oncology



American Association for Cancer Research Inc

American College of Physicians

GDS International Ltd

Member of Advisory Board
Biotechnology Industry Organization

Member of Advisory Board
All Conferences

Board Member

Member, Various Committees
American Association for Cancer Research Inc

Member of Advisory Board

Member, Various Committees
International Union


M.D. degree

University of Komenius

Web References (143 Total References)

Archive - symphogen

www.symphogen.com [cached]

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to treat cancer, infectious and autoimmune diseases, announced today the completion of its senior management team with the addition of a new Chief Scientific/Medical Officer, Ivan D. Horak, M.D.,FACP and a new Chief Business Officer, Gayle M Mills.

Scientific Advisory Board - symphogen

www.symphogen.com [cached]

Ivan D Horak

Executive Management - symphogen

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP Head of Global R&D, Chief Scientific and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.

Upcoming Events - symphogen

www.symphogen.com [cached]

Symphogen participants: Kirsten Drejer, Ivan Horak, Charles Conover, Amartya Basu, Gayle Mills, Jette Asboe Lassen, Johan Lantto, Michael Kragh, Thomas Tuxen Poulsen

Speaker: Ivan Horak (Clinical Advisory Meeting)
Symphogen participants: Ivan Horak
Immuno-Oncology Summit

Readmore - symphogen

www.symphogen.com [cached]

According to Symphogen Chief Scientific Officer and Medical Officer, Ivan D. Horak, MD, FACP,

Similar Profiles

Other People with this Name

Other people with the name Horak

Roman Horak
InfoTransec Inc

Ivan Horak
American Federation for Clinical Research

Michele Horak
Michael Baker Jr. , Inc.

Robert Horak
Lincoln International LLC

Olga Horak
Townstate Corporation

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory